Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV. 2013

Mark J Mitton-Fry, and Steven J Brickner, and Judith C Hamel, and Lori Brennan, and Jeffrey M Casavant, and Michael Chen, and Tao Chen, and Xiaoyuan Ding, and James Driscoll, and Joel Hardink, and Thuy Hoang, and Erbing Hua, and Michael D Huband, and Meghan Maloney, and Anthony Marfat, and Sandra P McCurdy, and Dale McLeod, and Michael Plotkin, and Usa Reilly, and Shaughn Robinson, and John Schafer, and Richard M Shepard, and James F Smith, and Gregory G Stone, and Chakrapani Subramanyam, and Kwansik Yoon, and Wei Yuan, and Richard P Zaniewski, and Christopher Zook
Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340, USA. mjmitton@owu.edu

A structurally novel set of inhibitors of bacterial type II topoisomerases with potent in vitro and in vivo antibacterial activity was developed. Dual-targeting ability, hERG inhibition, and pharmacokinetic properties were also assessed.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011804 Quinolines
D004250 DNA Topoisomerases, Type II DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex. DNA Topoisomerase (ATP-Hydrolysing),DNA Topoisomerase II,DNA Topoisomerase II alpha,DNA Topoisomerase II beta,DNA Type 2 Topoisomerase,TOP2A Protein,TOP2B Protein,Topoisomerase II,Topoisomerase II alpha,Topoisomerase II beta,Type II DNA Topoisomerase,alpha, Topoisomerase II,beta, Topoisomerase II
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D013296 Streptococcus pneumoniae A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals. Diplococcus pneumoniae,Pneumococcus

Related Publications

Mark J Mitton-Fry, and Steven J Brickner, and Judith C Hamel, and Lori Brennan, and Jeffrey M Casavant, and Michael Chen, and Tao Chen, and Xiaoyuan Ding, and James Driscoll, and Joel Hardink, and Thuy Hoang, and Erbing Hua, and Michael D Huband, and Meghan Maloney, and Anthony Marfat, and Sandra P McCurdy, and Dale McLeod, and Michael Plotkin, and Usa Reilly, and Shaughn Robinson, and John Schafer, and Richard M Shepard, and James F Smith, and Gregory G Stone, and Chakrapani Subramanyam, and Kwansik Yoon, and Wei Yuan, and Richard P Zaniewski, and Christopher Zook
July 2016, The Journal of antimicrobial chemotherapy,
Mark J Mitton-Fry, and Steven J Brickner, and Judith C Hamel, and Lori Brennan, and Jeffrey M Casavant, and Michael Chen, and Tao Chen, and Xiaoyuan Ding, and James Driscoll, and Joel Hardink, and Thuy Hoang, and Erbing Hua, and Michael D Huband, and Meghan Maloney, and Anthony Marfat, and Sandra P McCurdy, and Dale McLeod, and Michael Plotkin, and Usa Reilly, and Shaughn Robinson, and John Schafer, and Richard M Shepard, and James F Smith, and Gregory G Stone, and Chakrapani Subramanyam, and Kwansik Yoon, and Wei Yuan, and Richard P Zaniewski, and Christopher Zook
February 2023, Pharmaceuticals (Basel, Switzerland),
Mark J Mitton-Fry, and Steven J Brickner, and Judith C Hamel, and Lori Brennan, and Jeffrey M Casavant, and Michael Chen, and Tao Chen, and Xiaoyuan Ding, and James Driscoll, and Joel Hardink, and Thuy Hoang, and Erbing Hua, and Michael D Huband, and Meghan Maloney, and Anthony Marfat, and Sandra P McCurdy, and Dale McLeod, and Michael Plotkin, and Usa Reilly, and Shaughn Robinson, and John Schafer, and Richard M Shepard, and James F Smith, and Gregory G Stone, and Chakrapani Subramanyam, and Kwansik Yoon, and Wei Yuan, and Richard P Zaniewski, and Christopher Zook
April 2021, Pharmaceuticals (Basel, Switzerland),
Mark J Mitton-Fry, and Steven J Brickner, and Judith C Hamel, and Lori Brennan, and Jeffrey M Casavant, and Michael Chen, and Tao Chen, and Xiaoyuan Ding, and James Driscoll, and Joel Hardink, and Thuy Hoang, and Erbing Hua, and Michael D Huband, and Meghan Maloney, and Anthony Marfat, and Sandra P McCurdy, and Dale McLeod, and Michael Plotkin, and Usa Reilly, and Shaughn Robinson, and John Schafer, and Richard M Shepard, and James F Smith, and Gregory G Stone, and Chakrapani Subramanyam, and Kwansik Yoon, and Wei Yuan, and Richard P Zaniewski, and Christopher Zook
March 2019, Expert opinion on therapeutic patents,
Mark J Mitton-Fry, and Steven J Brickner, and Judith C Hamel, and Lori Brennan, and Jeffrey M Casavant, and Michael Chen, and Tao Chen, and Xiaoyuan Ding, and James Driscoll, and Joel Hardink, and Thuy Hoang, and Erbing Hua, and Michael D Huband, and Meghan Maloney, and Anthony Marfat, and Sandra P McCurdy, and Dale McLeod, and Michael Plotkin, and Usa Reilly, and Shaughn Robinson, and John Schafer, and Richard M Shepard, and James F Smith, and Gregory G Stone, and Chakrapani Subramanyam, and Kwansik Yoon, and Wei Yuan, and Richard P Zaniewski, and Christopher Zook
January 2018, Current computer-aided drug design,
Mark J Mitton-Fry, and Steven J Brickner, and Judith C Hamel, and Lori Brennan, and Jeffrey M Casavant, and Michael Chen, and Tao Chen, and Xiaoyuan Ding, and James Driscoll, and Joel Hardink, and Thuy Hoang, and Erbing Hua, and Michael D Huband, and Meghan Maloney, and Anthony Marfat, and Sandra P McCurdy, and Dale McLeod, and Michael Plotkin, and Usa Reilly, and Shaughn Robinson, and John Schafer, and Richard M Shepard, and James F Smith, and Gregory G Stone, and Chakrapani Subramanyam, and Kwansik Yoon, and Wei Yuan, and Richard P Zaniewski, and Christopher Zook
October 2014, Current opinion in pharmacology,
Mark J Mitton-Fry, and Steven J Brickner, and Judith C Hamel, and Lori Brennan, and Jeffrey M Casavant, and Michael Chen, and Tao Chen, and Xiaoyuan Ding, and James Driscoll, and Joel Hardink, and Thuy Hoang, and Erbing Hua, and Michael D Huband, and Meghan Maloney, and Anthony Marfat, and Sandra P McCurdy, and Dale McLeod, and Michael Plotkin, and Usa Reilly, and Shaughn Robinson, and John Schafer, and Richard M Shepard, and James F Smith, and Gregory G Stone, and Chakrapani Subramanyam, and Kwansik Yoon, and Wei Yuan, and Richard P Zaniewski, and Christopher Zook
July 2021, Bioorganic chemistry,
Mark J Mitton-Fry, and Steven J Brickner, and Judith C Hamel, and Lori Brennan, and Jeffrey M Casavant, and Michael Chen, and Tao Chen, and Xiaoyuan Ding, and James Driscoll, and Joel Hardink, and Thuy Hoang, and Erbing Hua, and Michael D Huband, and Meghan Maloney, and Anthony Marfat, and Sandra P McCurdy, and Dale McLeod, and Michael Plotkin, and Usa Reilly, and Shaughn Robinson, and John Schafer, and Richard M Shepard, and James F Smith, and Gregory G Stone, and Chakrapani Subramanyam, and Kwansik Yoon, and Wei Yuan, and Richard P Zaniewski, and Christopher Zook
January 2020, Bioorganic chemistry,
Mark J Mitton-Fry, and Steven J Brickner, and Judith C Hamel, and Lori Brennan, and Jeffrey M Casavant, and Michael Chen, and Tao Chen, and Xiaoyuan Ding, and James Driscoll, and Joel Hardink, and Thuy Hoang, and Erbing Hua, and Michael D Huband, and Meghan Maloney, and Anthony Marfat, and Sandra P McCurdy, and Dale McLeod, and Michael Plotkin, and Usa Reilly, and Shaughn Robinson, and John Schafer, and Richard M Shepard, and James F Smith, and Gregory G Stone, and Chakrapani Subramanyam, and Kwansik Yoon, and Wei Yuan, and Richard P Zaniewski, and Christopher Zook
January 2008, Methods in molecular medicine,
Mark J Mitton-Fry, and Steven J Brickner, and Judith C Hamel, and Lori Brennan, and Jeffrey M Casavant, and Michael Chen, and Tao Chen, and Xiaoyuan Ding, and James Driscoll, and Joel Hardink, and Thuy Hoang, and Erbing Hua, and Michael D Huband, and Meghan Maloney, and Anthony Marfat, and Sandra P McCurdy, and Dale McLeod, and Michael Plotkin, and Usa Reilly, and Shaughn Robinson, and John Schafer, and Richard M Shepard, and James F Smith, and Gregory G Stone, and Chakrapani Subramanyam, and Kwansik Yoon, and Wei Yuan, and Richard P Zaniewski, and Christopher Zook
May 2014, Journal of medicinal chemistry,
Copied contents to your clipboard!